Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells

Verfasser / Beitragende:
[R. S. BelAiba, T. Djordjevic, S. Bonello, D. Flügel, J. Hess, T. Kietzmann, A. Görlach]
Ort, Verlag, Jahr:
2004
Enthalten in:
Biological Chemistry, 385/3-4(2004-04-13), 249-257
Format:
Artikel (online)
ID: 378919970
LEADER caa a22 4500
001 378919970
003 CHVBK
005 20180305123602.0
007 cr unu---uuuuu
008 161128e20040413xx s 000 0 eng
024 7 0 |a 10.1515/BC.2004.019  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/BC.2004.019 
245 0 0 |a Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells  |h [Elektronische Daten]  |c [R. S. BelAiba, T. Djordjevic, S. Bonello, D. Flügel, J. Hess, T. Kietzmann, A. Görlach] 
520 3 |a Pulmonary hypertension and vascular remodeling processes are associated with oxidative stress, hypoxia and enhanced levels of thrombin and vascular endothelial growth factor (VEGF). The hypoxia-inducible transcription factor HIF regulates the expression of VEGF under hypoxia. The HIF pathway is also activated by thrombin or CoCl2, likely via reactive oxygen species (ROS). In this study we investigated whether the redox-modifying enzymes superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase affect HIF levels and the expression of VEGF mRNA in pulmonary artery smooth muscle cells (PASMC). Stimulation of PASMC with thrombin or CoCl2 increased ROS production and enhanced HIFα protein and VEGF mRNA levels as well as HIFdependent reporter gene activity. These responses were inhibited by vitamin C and by overexpression of GPX and catalase, whereas the opposite effects were observed in SOD-expressing cells. These findings suggest that an antioxidant state with reduced levels of H2O2 limits the activation of the HIF pathway, whereas a prooxidant state allowing elevated H2O2 levels promotes it. Thus, shifting the redox balance to a more reduced environment, thereby limiting VEGF expression, may be beneficial for treating remodeling processes during pulmonary hypertension. 
540 |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Biochemistry  |2 nationallicence 
690 7 |a Molecular biology  |2 nationallicence 
690 7 |a Cellular biology  |2 nationallicence 
700 1 |a BelAiba  |D R. S.  |4 aut 
700 1 |a Djordjevic  |D T.  |4 aut 
700 1 |a Bonello  |D S.  |4 aut 
700 1 |a Flügel  |D D.  |4 aut 
700 1 |a Hess  |D J.  |4 aut 
700 1 |a Kietzmann  |D T.  |4 aut 
700 1 |a Görlach  |D A.  |4 aut 
773 0 |t Biological Chemistry  |d Walter de Gruyter  |g 385/3-4(2004-04-13), 249-257  |x 1431-6730  |q 385:3-4<249  |1 2004  |2 385  |o bchm 
856 4 0 |u https://doi.org/10.1515/BC.2004.019  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/BC.2004.019  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a BelAiba  |D R. S.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Djordjevic  |D T.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bonello  |D S.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Flügel  |D D.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hess  |D J.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kietzmann  |D T.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Görlach  |D A.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biological Chemistry  |d Walter de Gruyter  |g 385/3-4(2004-04-13), 249-257  |x 1431-6730  |q 385:3-4<249  |1 2004  |2 385  |o bchm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter